Neutrophil-to-lymphocyte ratio for primary risk stratification in acute pancreatitis: a systematic review and meta-analysis
Serge Chooklin, Serhii Chuklin

TL;DR
This study shows that the neutrophil-to-lymphocyte ratio (NLR) can help predict severe outcomes in acute pancreatitis patients early on, improving risk stratification and care decisions.
Contribution
The study demonstrates the NLR's utility in predicting severe disease, organ failure, infection, and mortality in acute pancreatitis through systematic review and meta-analysis.
Findings
Elevated admission NLR is linked to severe disease and early intensive care needs.
NLR measurements on day 1 and day 2 help identify patients at risk of persistent organ failure.
NLR > 12 at admission is associated with in-hospital mortality.
Abstract
Early risk stratification in acute pancreatitis should address not only the probability of severe disease but also the timely prediction of persistent organ failure, (POF) infectious complications [including infected pancreatic necrosis (IPN)], and mortality. The neutrophil-to-lymphocyte ratio (NLR) is a low-cost, first-line biomarker that is readily obtainable within the initial 24–48 h. To evaluate the clinical utility of the NLR for predicting a severe disease course, persistent organ failure, infection, and mortality across predefined, time-specific measurement windows. We conducted a systematic review with meta-analytic synthesis of studies assessing the NLR at admission and during the first two days of hospitalization. Random-effects models were used, and bivariate approaches were applied to synthesize diagnostic accuracy. Elevated admission NLR was consistently associated with…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPancreatitis Pathology and Treatment · COVID-19 Clinical Research Studies · Inflammatory Biomarkers in Disease Prognosis
